Jardiance | Empagliflozin Tablet Breastfeeding
Modern medicine has evolved so much so that sooner or later every breastfeeding mother needs to take it in one form or other. Medication that is present in mothers blood will transfer into her breast milk to some extent. Most drugs do so at low levels and pose no real risk to infants but then there are some exceptions. In This post will discuss whether Jardiance | Empagliflozin Tablet is safe in breast-feeding or not.

What is Jardiance | Empagliflozin Tablet used for?


JARDIANCE is indicated: as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus, to reduce the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and established cardiovascular disease. Limitations of Use JARDIANCE is not recommended for patients with type 1 diabetes or for the treatment of diabetic ketoacidosis. JARDIANCE is a sodium-glucose co-transporter 2 (SGLT2) inhibitor indicated: as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus, to reduce the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and established cardiovascular disease. ( 1) Limitations of Use: Not for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis ( 1)

Jardiance | Empagliflozin Tablet while breastfeeding safe or not? Can there be any side effects for infant while using it during breastfeeding?

Jardiance | Empagliflozin Tablet high risk while breastfeeding
As Jardiance | Empagliflozin Tablet is made of only Empagliflozin, and Empagliflozin is unsafe to use in breastfeeding we can safely reach on conclusion that Jardiance | Empagliflozin Tablet is also unsafe to use while breastfeeding. Below is detailed analysis of Empagliflozin and Jardiance | Empagliflozin Tablet during location. We recommend you to go through provided detailed analysis as below take decision accordingly. We also recommend you talk to your health care provider before making final decision.

Jardiance | Empagliflozin Tablet Breastfeeding Analsys


Empagliflozin while Breastfeeding

Unsafe

CAS Number: 461432-26-8

Dapagliflozin is a selective and reversible inhibitor of the sodium and glucose co-transporter 2 (SGLT2). It acts by reducing the renal reabsorption of glucose and increasing its elimination via urine (Kasichayanula 2014, Plosker 2014).Administered orally once a day. Low risk of hypoglycemia in monotherapy, which increases when it is associated with other hypoglycaemic agents (EMA 2017, Plosker 2014). Since the last update, we have not found published data on its excretion in breast milk. Its high percentage of protein binding (EMA 2017) makes its transfer to milk in significant quantities unlikely, but the low molecular weight and its elimination half-life greater than 12 hours could facilitate a possible transfer. Until there is more published data on this drug in relation to breastfeeding, safer known alternatives may be preferable, especially during the neonatal period and in case of prematurity. Diet, exercise and breastfeeding improve blood glucose levels.


Jardiance | Empagliflozin Tablet Breastfeeding Analsys - 2


Empagliflozin while Breastfeeding

CAS Number: 461432-26-8

No information is available on the clinical use of empagliflozin during breastfeeding. Empagliflozin is an uncharged molecule that is 86% protein bound in plasma, so it is unlikely to pass into breastmilk in clinically important amounts. The manufacturer does not recommend empagliflozin during breastfeeding because of a theoretical risk to the infant's developing kidney. An alternate drug may be preferred, especially while nursing a newborn or preterm infant.



I am nursing mother and I have already used Jardiance | Empagliflozin Tablet, what should I do?

We have already established that Jardiance | Empagliflozin Tablet is unsafe in breastfeeding and breastfeeding while using Jardiance | Empagliflozin Tablet is not a good idea however if have already used and then breastfed the baby then you shall monitor the behavior and health of baby closely and inform your doctor as soon as possible. In case of emergency please call 911.


I am nursing mother and my doctor has suggested me to use Jardiance | Empagliflozin Tablet, is it safe?

If your doctor knows that you are breastfeeding mother and still prescribes Jardiance | Empagliflozin Tablet then there must be good reason for that as Jardiance | Empagliflozin Tablet is considered unsafe, It usually happens when doctor finds that overall advantage of taking outweighs the overall risk.


If I am using Jardiance | Empagliflozin Tablet, will my baby need extra monitoring?

Yes, Extra monitoring is required if mother is using Jardiance | Empagliflozin Tablet and breastfeeding as it is considered unsafe for baby.


Who can I talk to if I have questions about usage of Jardiance | Empagliflozin Tablet in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week